Neuman, G., Boodhan, S., Wurman, I., Koren, G., Kirby-Allen, M. and Ito, S. (2014) Ceftriaxone-Induced Immune Hemolytic Anemia. Annals of Pharmacotherapy, 48, 1594-1604.
https://doi.org/10.1177/1060028014548310

has been cited by the following article:

• TITLE: Drug-Induced Hemolytic Anemia: A Fatal Complication Further Under-Recognized in Sickle Cell Disease

  AUTHORS: Monica Khurana, Shekhar S. Raj

  KEYWORDS: Sickle Cell, Hemolytic Anemia, Blood Bank, Pathology

  JOURNAL NAME: Open Journal of Blood Diseases, Vol.7 No.3, September 25, 2017

  ABSTRACT: Drug-induced immune hemolytic anemia (DIIHA) is commonly attributed to cephalosporins. Ceftriaxone is the most frequently administered cephalosporin in patients with sickle cell disease. We present a pediatric patient with severe DIIHA (hemoglobin